NEW YORK, 26 July (Praxis Press) The human immunodeficiency virus (HIV) lipodystrophy syndrome is characterized by fat redistribution and insulin resistance; this syndrome is particularly common among ...

Lipodystrophy refers to different signs and symptoms in people living with HIV and is not one syndrome with a single cause. The mechanisms underlying lipodystrophy development in HIV-positive people ...

lipodystrophy, and metabolic syndrome, and their grave cardiovascular and metabolic complications. In modern societies, characterized by sedentary lifestyles and high-calorie diets, adipose tissue ...

Rosiglitazone and metformin had differing modest effects on fat and plasma lipid parameters associated with HIV lipodystrophy. Metformin and rosiglitazone have both been evaluated for the ...

for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy. Each single-patient-use vial of Egrifta WR contains tesamorelin 11.6mg (equivalent to approximately 11 ...

Tesamorelin for injection is the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy. The new formulation, EGRIFTA WR™, is a ...